According to Heartflow, its AI offering saves health systems nearly $1,400 per patient thanks to reductions in unnecessary cardiovascular testing.

In some cases, it may actually be more beneficial for this group of women to forego the extra scans, as they can lead to additional testing, costs and potentially delays in care.

The tracer's extended half-life of over three hours could make it a promising candidate for future prostate cancer diagnostics. 

For years, imaging experts have predicted that CCTA may become the primary imaging modality for coronary artery disease and eliminate the need for invasive diagnostic catheterizations. That prediction is now coming true.

“There is enormous potential here, and the [American Cancer Society] is thrilled with the outcome of this study," one investigators says. 

Data presented during the RSNA 2025 annual meeting question the legitimacy of high priority magnetic resonance imaging orders. 

Leaders from both companies are optimistic about how their partnership can improve precision medicine and palliative therapies. 

MRI is an essential tool for diagnosing and managing the disease, but poor image quality and interpretation variability continue to hinder its widespread adoption